{"title":"New product intros [ADV-7103 (new combination), asparaginase Erwinia chrysanthemi, empagliflozin (new indication), MVC-COV-1901, ON-101, penpulimab, ponesimod, sotorasib, upacicalcet sodium hydrate, upadacitinib tartrate (new indication), zimberelimab, ZyCoV-D]","authors":"","doi":"10.1358/dot.2021.57.11.3381582","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"50 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicamentos de actualidad. Drugs of today","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1358/dot.2021.57.11.3381582","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
新产品介绍[ADV-7103(新组合),菊Erwinia,恩格列净(新适应症),MVC-COV-1901, ON-101,彭普利单抗,ponesimod, sotorasib, upacicalcet sodium hydrate, upadacitinib酒石酸盐(新适应症),zimberelimab, ZyCoV-D]
本文章由计算机程序翻译,如有差异,请以英文原文为准。